Periodic Fever Market, By Disease Type (Familial Mediterranean Fever, TNF Receptor–Associated Periodic Syndrome, Mevalonate Kinase Deficiency, Cryopyrin-Associated Periodic Syndromes, PFAPA Syndrome, and Systemic Autoinflammatory Periodic Fevers), By Treatment Type (Biologic Therapies, Corticosteroids, Colchicine Therapy, NSAIDs & Symptomatic Treatments, Immunosuppressants, and Emerging Targeted Therapies & Gene-based Treatments), By Route of Administration (Injectable, Oral, and Intravenous Infusion), By Diagnosis Type (Genetic Testing, Laboratory & Biomarker Testing, Clinical Diagnosis, and Imaging & Supportive Diagnostic Methods), By Patient Group (Pediatric Patients and Adult Patients), By End User (Hospitals, Specialty & Rheumatology Clinics, Ambulatory Surgical Centers, and Homecare Settings), By Distribution Channel (Online and Offline), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East and Africa)